Professional Documents
Culture Documents
Nm-Lec17 - Psychoactive Agents & Lithium
Nm-Lec17 - Psychoactive Agents & Lithium
LITHIUM
Phenothiazines
Thioxanthene
Butyrophenone
Atypical Psychotics
Lithium
Newer Agents for Bipolar Disorder
PHENOTHIAZINES & THIOXANTHENE
1. CHLORPROMAZINE
2. FLUPHENAZINE 1. THIOTHIXENE
3. THIORIDAZINE
MECHANISM OF ACTION
Blockade of D2 receptors >>
5HT2A receptors
CLINICAL APPLICATIONS
• 1. PSYCHIATRIC:
• •Schizophrenia (alleviate positive symptoms)
• •Bipolar Disorder (manic phase)
• 2. NONPSYCHIATRIC:
• •Anti-emesis
• •Preoperative sedation
• 3. Pruritus
BUTYROPHENONE
1. HALOPERIDOL
MECHANISM OF ACTION
Blockade of D2 receptors >>
5HT2A receptors
CLINICAL APPLICATIONS
• 1. SCHIZOPRENIA (alleviates positive
symptoms)
• 2. BIPOLAR DISORDER (manic phase)
• 3. HUNTINGTON’S CHOREA
• 4.TOURETTE’S SYNDROME
ATYPICAL ANTIPSYCHOTICS
1. ARIPIRAZOLE
2. CLOZAPINE
3. OLANZAPINE
4. QUETIAPINE
5. RISPERIDONE
6. ZIPRASIDONE
MECHANISM OF ACTION
Blockade of D2 receptors >>
5HT2A receptors
CLINICAL APPLICATIONS
• 1. SCHIZOPRENIA (improve both positive and
negative symptoms)
• 2. BIPOLAR DISORDER (olanzapine or
risperidone adjunctive with lithium)
• 3. Agitation in ALZHEIMER’S & PARKINSON’S
(low doses)
• 4. MAJOR DEPRESSION (aripiprazole)
LITHIUM
MECHANISM OF ACTION
CLINICAL APPLICATIONS
• 1. BIPOLAR AFFECTIVE DISORDER
• 2. PROPHYLACTIC USE can prevent mood
swings between mania and depression
NEWER AGENTS FOR BIPOLAR
DISORDER
1. CARBAMAZEPINE
2. LAMOTRIGINE
3. VALPROIC ACID
MECHANISM OF ACTION